Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03695510 |
|---|---|
| Brief Title: | Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study) (ALPHA) |
| First Submitted : | October 1, 2018 |
| First Submitted that Met QC Criteria : | October 3, 2018 |
| First Posted : | October 4, 2018 |
| Last Update Submitted that Met QC Criteria : | April 19, 2022 |
| Last Update Posted : | April 21, 2022 |